Virtual Roundtable: Intellectual Property

IP_Roundtable.jpeg

Intellectual Property Issues for Bioinformatics
and Health Information Management Entrepreneurs

Thursday, January 24, 2019, 12-1:30 pm EST Online
Register Now

Speakers:
Scott D. Locke, Esq., Partner & Chair
     Intellectual Property Department, Dorf & Nelson
Laura Smalley, Esq., Member, Harris Beach
Moderator:
Christopher C. Palermo, Esq., Senior Counsel
Harris Beach

Patent guidelines and recommendations vary by discipline, from molecules to devices to computer codes. In our current age, digital innovation is a necessity for all businesses. Researchers and entrepreneurs are responsible for understanding how this innovation and ownership is protected.

Among the most rapidly growing sub-disciplines in the biotechnology industry are the management and manipulation of data, the creation of code for bioinformatics and personalization of medicine, and the creation of Apps. Protection of and capitalization on these assets can be challenging, particularly because of recent trends in U.S. patent law that have narrowed the types of inventions that are eligible for patent protection.

Scott Locke.jpg

This roundtable will explore the current patent landscape, the business implications of this landscape, and strategies outside of patent protection for businesses whose innovations are in these areas.

Laura Smalley.jpg

Scott Locke counsels clients on the procurement, enforcement, and licensing of patents, trademarks, copyrights, and trade secrets. He provides solo inventors, start-up businesses, and well-established companies across diverse industries with strategies and tools for maximizing the return on their investment in their ingenuity, creativity, and goodwill. His clients include innovators in the fields of pharmaceuticals, delivery systems, diagnostics, siRNA technologies, Cas9 related technologies, gene therapies, and medical devices.

Laura Smalley represents clients in a wide range of complex commercial matters, including patent, trademark, and business litigation. She is a member of Harris Beach’s Business & Commercial Litigation, Intellectual Property, and Appellate Litigation & Advocacy Practice Groups. Laura is also a member of Harris Beach's Electronic Information Counseling and Management Team and the Nanotechnology Industry Team.

Chris Palermo.jpg

Christopher Palermo is a senior counsel at Harris Beach with experience representing pharmaceutical companies in government investigations, class action litigation, antitrust matters, and claims brought by the U.S. Department of Justice and state Attorneys General involving marketing and pricing practices. He has experience representing companies in disputes involving intellectual property, trade secrets and unfair competition claims. He also has advised clients in the life sciences industry on a variety of compliance issues. He is a member of the Executive Committee of the Food, Drug and Cosmetic Law Section of the New York State Bar Association.